REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/28/2025
Back to search
Official data from USPTO
F-STAR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
F-STAR
ST13
US500000088391681Class
1, 5, 42
Filing
88391681
Registration
6040409
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
04/29/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
04/18/2019
Registration date
04/28/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2020
Last transaction
04/29/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
11
Owner location
WHITE CITY PLACE, GB
Examiner
WHITTAKER BROWN, TRACY
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
INVOX PHARMA LIMITED
F-STAR THERAPEUTICS LIMITED
F-star Biotechnology Ltd.
Representatives
Shoko Naruo THOMPSON COBURN LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical and biological preparations for scientific usein particular libraries of immunoglobulinsantibodiesfragments thereof
Class 5
Pharmaceutical preparationsin particular preparations based on immunoglobulinsantibodiesparts thereof for treatment of cancerinfectious diseasesinflammation and diseases and conditions associated with inflammationinflammatory diseasesneurological diseases; Pharmaceutical and biopharmaceutical preparationsincluding drugsfor medical usein particular immunoglobulinsantibodiesfragments thereofpreparations for treatment of cancerinfectious diseasesinflammation and diseases and conditions associated with inflammationinflammatory diseasesneurological diseases
Class 42
Scientific and technological servicesscientific research and design in the field of pharmaceutical and biopharmaceutical products; Drug discovery services; Scientific research for medical purposes in the field of medicines; Research and development of medicines; Product development for othersdevelopment of pharmaceutical preparations and medicines; Scientific researchindustrial analysis and research servicesin particular for selecting and preparing immunoglobulinsantibodiesparts thereof for medical purposes
Publications
History of USPTO decisions and trademark events.
18 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/30/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/19/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/11/2020
PUBO
PUBLISHED FOR OPPOSITION
02/11/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/22/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/07/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/20/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/20/2019
ALIE
ASSIGNED TO LIE
12/18/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/05/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/27/2019
GNRT
NON-FINAL ACTION E-MAILED
06/27/2019
CNRT
NON-FINAL ACTION WRITTEN
06/27/2019
DOCK
ASSIGNED TO EXAMINER
06/27/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/04/2019
NWAP
NEW APPLICATION ENTERED
04/22/2019
Continuous trademark protection
Get notified about every new filing that threatens F-STAR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.